Does the electrocardiographic presence of Q waves influence the survival of patients with acute myocardial infarction?

AIMS To compare the outcome of short- and long-term survival of patients with Q wave vs non-Q wave myocardial infarction. METHODS A total of 6676 patients with acute myocardial infarction were enrolled on the TRAndolapril Cardiac Evaluation (TRACE) register between 1990 and 1992. Medical history, electrocardiographic diagnosis of Q wave and non-Q wave myocardial infarction, echocardiographic estimation of left ventricular systolic function determined as wall motion index, infarct complications, and survival were documented. The factors influencing the postmyocardial infarction outcome of these patients were studied after 30 days and after 8 years of follow-up, respectively. RESULTS Cox proportional-hazard models demonstrated that the electrocardiographic Q waves had significant influence on survival during the first 30 days [risk ratio 1.4 (95% confidence limits 1.2-1.7)] but no influence thereafter [1.0 (0.9-1.1)]. The result was the same in univariate and multivariate analyses. Subgroup analysis defined by age, sex, wall motion index, presence of congestive heart failure, diabetes mellitus, arterial hypertension, subsequent myocardial infarctions and use of thrombolytic therapy did not disclose importance of Q waves on mortality. CONCLUSION The electrocardiographic presence of Q waves is associated with increased mortality during the initial 30 days after a myocardial infarction, but has no influence thereafter.

[1]  A. Moss,et al.  The prognostic significance of first myocardial infarction type (Q wave versus non-Q wave) and Q wave location. The Multicenter Diltiazem Post-Infarction Research Group. , 1990, Journal of the American College of Cardiology.

[2]  A. Skene,et al.  Late assessment of thrombolytic efficacy (LATE) study: Prognosis in patients with non-Q wave myocardial infarction , 1996 .

[3]  B Rosner,et al.  Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison. , 1984, Circulation.

[4]  J. Hansen,et al.  Verapamil in Acute Myocardial Infarction , 1980, Danish medical bulletin.

[5]  R. Califf,et al.  Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators. , 1998, Circulation.

[6]  R. Califf,et al.  Thrombolysis and Q wave versus non-Q wave first acute myocardial infarction: a GUSTO-I substudy. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries Investigators. , 1997, Journal of the American College of Cardiology.

[7]  E. Negri,et al.  Determinants of 6‐Month Mortality in Survivors of Myocardial Infarction After Thrombolysis Results of the GISSI‐2 Data Base , 1993, Circulation.

[8]  A. Moss,et al.  Q-wave versus non-Q wave myocardial infarction: a meaningless distinction. , 1999, Journal of the American College of Cardiology.

[9]  H. Hod,et al.  Prognostic importance of delayed Q-wave evolution 3 to 24 hours after initiation of thrombolytic therapy for acute myocardial infarction. , 1991, The American journal of cardiology.

[10]  A. Moss,et al.  Risk of subsequent cardiac events in stable convalescing patients after first non‐Q-wave and Q‐wave myocardial infarction: the limited role of non‐invasive testing , 1994, Coronary artery disease.

[11]  J. Miller,et al.  Long-term prognosis after first Q-wave (transmural) or non-Q-wave (nontransmural) myocardial infarction: analysis of 593 patients. , 1983, The American journal of cardiology.

[12]  J. Miller,et al.  Electrocardiographic subset analysis of diltiazem administration on long-term outcome after acute myocardial infarction. The Multicenter Diltiazem Post-Infarction Trial Research Group. , 1991, The American journal of cardiology.

[13]  J. Muller,et al.  Significance of location (anterior versus inferior) and type (Q-wave versus non-Q-wave) of acute myocardial infarction in patients undergoing percutaneous transluminal coronary angioplasty for postinfarction ischemia. , 1995, The American journal of cardiology.

[14]  A. Weyman,et al.  Cross-sectional Echocardiographic Analysis of the Extent of Left Ventricular Asynergy in Acute Myocardial Infarction , 1980, Circulation.

[15]  A. Camm,et al.  The TRAandolapril cardiac evaluation (TRACE) study : rationale, design, and baseline characteristics of the screened population , 1994 .

[16]  J. Wittes,et al.  Evaluating effects of treatment in subgroups of patients within a clinical trial: the case of non-Q-wave myocardial infarction and beta blockers. , 1990, The American journal of cardiology.

[17]  B. Rodda The Timolol Myocardial Infarction Study: an evaluation of selected variables. , 1983, Circulation.

[18]  L. Klein,et al.  The non-Q wave myocardial infarction revisited: 10 years later. , 1997, Progress in cardiovascular diseases.

[19]  J. Miller,et al.  In‐hospital Prognosis of Patients with First Nontransmural and Transmural Infarctions , 1980, Circulation.

[20]  M. Gheorghiade,et al.  Decline in the rate of hospital mortality from acute myocardial infarction: impact of changing management strategies. , 1996, American heart journal.

[21]  J. V. Nixon Non-Q-wave myocardial infarction. , 1986, American Journal of the Medical Sciences.

[22]  P. Andersen,et al.  Rapid estimation of left ventricular ejection fraction in acute myocardial infarction by echocardiographic wall motion analysis. , 1992, Cardiology.

[23]  M. Gheorghiade,et al.  Effects of propranolol in non-Q-wave acute myocardial infarction in the beta blocker heart attack trial. , 1990, The American journal of cardiology.

[24]  J. W. Kennedy,et al.  Non-Q-wave myocardial infarction. , 1986, Lancet.

[25]  E. Gilpin,et al.  Short- and long-term clinical outcome after Q wave and non-Q wave myocardial infarction in a large patient population. , 1989, Circulation.

[26]  Rodda Be The Timolol Myocardial Infarction Study: an evaluation of selected variables. , 1983 .

[27]  L. Shaw,et al.  Early and 1-year clinical outcome of patients' evolving non-Q-wave versus Q-wave myocardial infarction after thrombolysis. Results from The TIMI II Study. , 1995, Circulation.

[28]  S. Gottlieb,et al.  Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. , 1998, The New England journal of medicine.

[29]  H. Hod,et al.  Q wave and Non-Q wave myocardial infarction after thrombolysis. , 1995, Journal of the American College of Cardiology.

[30]  L. Wilkins Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. , 1994, Circulation.

[31]  J. Kjekshus,et al.  Evolution of infarct size during the early use of nifedipine in patients with acute myocardial infarction: the Norwegian Nifedipine Multicenter Trial. , 1984, Circulation.

[32]  A. Jaffe,et al.  Prognostic significance of location and type of myocardial infarction: independent adverse outcome associated with anterior location. , 1988, Journal of the American College of Cardiology.